News Detail

BioQ Pharma to Present at the 38th Annual Canaccord Genuity Growth Conference

Aug 03, 2018

SAN FRANCISCO, Aug 3, 2018: BioQ Pharma Incorporated, a specialty pharmaceutical company, announced today that the Company will be presenting at the 38th Annual Canaccord Genuity Growth Conference to be held in Boston Massachusetts on August 8th and 9th, 2018.

Josh Kriesel, President and Chief Executive Officer, is scheduled to present on Wednesday, August 8th at 12:30 p.m. Eastern Daylight Time.

About BioQ Pharma

BioQ Pharma Incorporated is a privately held specialty pharmaceutical company focused on developing and commercializing ready-to-use infusible pharmaceuticals. The Company's infusion platform is intended to address some of the most pressing unmet needs in drug infusion today: cost, medication error, sterility, efficiency, and patient quality of life. BioQ Pharma's vision is to set a new standard of care in the presentation and administration of infusible pharmaceuticals via the Company's proprietary unit-dose infusion systems that can be deployed quickly and conveniently at the point of care with one touch. The Company is ISO13485 certified. BioQ Pharma's commercial collaborators and strategic partners include Novartis' Sandoz unit, Stada, Cipla, Lee's Pharm, Lunatus, Galen Limited, Sophos Biotech, POA Pharma, Xantis Pharma, and West Pharmaceutical Services.

Company Contact Information:

Josh Kriesel
BioQ Pharma Incorporated
President and CEO

Ron Pauli
BioQ Pharma Incorporated
Chief Financial Officer